Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
S. Ito, K. Takeda, Y. Kawasaki, H. Izumi, T. Sakamoto, H. Touge, M. Kodani, S. Matsumoto, K. Araki, A. Yamasaki, T. Igishi, E. Shimizu (Yonago, Kashiwa, Japan). Correlation between EGFR mutations and emphysematous changes in heavy smokers with lung cancer. Eur Respir J 2013; 42: Suppl. 57, 4506

Member's Comments

Priya Darshan (North Ryde, Australia) - 09.09.2013 13:24
DEAR SIR, MAY I PLEASE HAVE A COPY OF YOUR WORK. I AM FROM NOVARTIS AUSTRALIA AND IF YOU ARE AT THE ERS CAN I PLEASE MEETING WITH YOU. BEST REGARDS PRIYA DARSHAN (PRIYA.DARSHN@NOVARTIS.COM)

Related content which might interest you: Is residential radon associated with mutations in drivers genes in never smokers lung cancer cases? The case of EGFR and ALK Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer Year: 2016 Prevalence of molecular changes in resected pulmonary adenocarcinomas Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Frequency and type of EGFR mutations in patients with adenocarcinoma of the lung Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 MUC1 associates with smoking, prognosis and histological subtypes in lung adenocarcinoma Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 Significance of EGFR expression patterns in patients with non-small cell lung cancer – Evaluation on protein- and/or gene level? Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Differences in epidemiological and clinical features in non-small cell lung cancer (NSCLC) in never and ever smokers Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Is there a difference in the incidence of metastasis at diagnosis of lung cancer between smokers and non smokers? Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Cytological samples for the study of EGFR, KRAS and ALK mutations in non-small cell lung cancer Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 Lung cancer in never smokers. A survival analysis in a radon prone area Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015 Prognostic value of survivin gene promoter polymorphisms in non-small cell lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Mutational status predicts the risk of thromboembolic events in lung adenocarcinoma Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Metabolomic profiles in lung cancer subjects and healthy controls. Influence of smoking tobacco exposure Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Automated target-FISH lung cancer detection (LCD) test of induced sputum Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 EGFR mutations determine EGFR-MET crosstalk and MET inhibition in lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 EGFRmutations are associated with higher brain metastasis radio-sensitivity than KRAS mutations or wild type EGFR in non-small cell lung cancer patients (NSCLC) Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Clinical characteristics of 32 patients with BRAF V600E-mutated lung adenocarcinoma Source: International Congress 2015 – Advances in the therapy of lung cancer Year: 2015 Breast metastasis from primary EGFR-mutated lung carcinoma or primary tumor? Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 Lung adenocarcinoma with concomitant EGFR mutation and ALK rearrangement: Analysis of two cases and literature review Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 Accelerated lung function decline increases the risk of lung cancer Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 EGFR frequency and response to chemotherapy in a Brazilian NSCLC population Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013